KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Equity Average (2016 - 2025)

Globus Medical (GMED) has disclosed Equity Average for 13 consecutive years, with $4.3 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Average rose 8.06% year-over-year to $4.3 billion, compared with a TTM value of $4.3 billion through Sep 2025, up 8.06%, and an annual FY2024 reading of $4.1 billion, up 39.88% over the prior year.
  • Equity Average was $4.3 billion for Q3 2025 at Globus Medical, up from $4.2 billion in the prior quarter.
  • Across five years, Equity Average topped out at $4.3 billion in Q3 2025 and bottomed at $1.5 billion in Q1 2021.
  • Average Equity Average over 5 years is $2.8 billion, with a median of $1.9 billion recorded in 2023.
  • The sharpest move saw Equity Average surged 126.71% in 2023, then increased 0.75% in 2024.
  • Year by year, Equity Average stood at $1.7 billion in 2021, then grew by 4.36% to $1.8 billion in 2022, then soared by 126.71% to $4.1 billion in 2023, then increased by 0.75% to $4.1 billion in 2024, then rose by 5.43% to $4.3 billion in 2025.
  • Business Quant data shows Equity Average for GMED at $4.3 billion in Q3 2025, $4.2 billion in Q2 2025, and $4.1 billion in Q1 2025.